The efficacy and safety of thrombolytic agents for patients with cerebral infarction
Sign Up to like & getrecommendations! Published in 2018 at "Medicine"
DOI: 10.1097/md.0000000000013762
Abstract: Background: Cerebral infarction is a commonly dangerous disease also with high morbidity and mortality. Thrombolytic agent is an effective method to treat it, but their relative efficacy and safety are unclear. A network meta-analysis (NMA)… read more here.
Keywords: efficacy safety; cerebral infarction; thrombolytic agents; agents patients ... See more keywords
In Vitro Evaluation of Capturing and Dissolving the Clot by Magnetic Nanoparticles Carrying a Thrombolytic Agents Instead of Temporary Inferior Vena Cava (IVC) Filter.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of biomedical nanotechnology"
DOI: 10.1166/jbn.2020.29941623
Abstract: This study aims to evaluate the efficiency of a novel in vitro technique in clot capturing and dissolving them by applying magnetic force on magnetic nanoparticles (MNP) carrying thrombolytic agents. It is a quick and… read more here.
Keywords: clot; carrying thrombolytic; magnetic nanoparticles; thrombolytic agents ... See more keywords
Endovascular Therapy for Venous Thromboembolic Diseases.
Sign Up to like & getrecommendations! Published in 2021 at "Acta Cardiologica Sinica"
DOI: 10.6515/acs.202111_37(6).20210505b
Abstract: Thrombolytic therapy plays an important role in treating venous thromboembolic events in patients with unstable hemodynamics or compromised limb circulation. Standard catheter-directed thrombolysis requires a lower dosage of thrombolytic agents than systemic thrombolysis, thus lowering… read more here.
Keywords: venous thromboembolic; therapy; thrombolytic agents; thromboembolic diseases ... See more keywords